This virtual dialogue took place on Thursday, May 14, 2020 and was Part 2 of a three-part series called Innovation on Demand: Strategies for Addressing Family Violence During COVID-19. The recording and transcript, along with resources shared by the presenters, are available through the links below.
Click here to view the recording of Innovation on Demand Part 2.
Click here to download the closed-captioning transcript (Word).
Click here to learn more, and to access resources from Parts 1 and 3.
Materials shared by the QIC-DVCW:
Tip Sheet 2 – Child Welfare Screening of Domestic Violence During COVID-19 – English (PDF)
Materials shared by SAFE Alliance:
The Parent Quick Glance to a Child Protective Investigation – Spanish (PDF)
The Parent Quick Glance to a Child Protective Investigation – English (PDF)
The Family Violence Safety Planning During COVID-19 – English (PDF)
The Guide to Working with Survivors Who Have an Open CPI/CPS Case During COVID-19 – English (PDF)
Materials shared by West Virginia Coalition Against Domestic Violence:
Description:
In Part 2, presenters share new ways they are working with community partners when there are concerns about family violence. The webinar focused on partnerships between child welfare and domestic violence professionals, including during child welfare screening and investigation. Presenters shared why collaboration is important to effectively help families experiencing domestic violence when there are safety concerns.
Presenters:
Questions? Accessibility Needs? Please contact Jess Fournier at jfournier@futureswithoutviolence.org
These webinars are funded through the Department of Health and Human Services, Administration for Children and Families, Children’s Bureau, Grant #90CA1850-01, and Grant Number 90EV0434-01-00 from the Administration on Children, Youth and Families, Family and Youth Services Bureau, U.S. Department of Health and Human Services. The content of these webinars does not necessarily reflect the view or policies of the funder, nor does mention of trade names, commercial products or organizations imply endorsement by the US Department of Health and Human Services.